Cadila Healthcare trades higher on the BSE

05 Jul 2021 Evaluate

Cadila Healthcare is currently trading at Rs. 642.80, up by 3.85 points or 0.60% from its previous closing of Rs. 638.95 on the BSE.

The scrip opened at Rs. 643.70 and has touched a high and low of Rs. 646.30 and Rs. 638.50 respectively. So far 96931 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 673.70 on 12-May-2021 and a 52 week low of Rs. 350.35 on 27-Jul-2020.

Last one week high and low of the scrip stood at Rs. 655.00 and Rs. 626.50 respectively. The current market cap of the company is Rs. 66016.04 crore.

The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 16.53% and 8.40% respectively.

Cadila Healthcare’s wholly-owned indirect subsidiary-- Viona Pharmaceuticals Inc is recalling over 21,000 bottles of metformin hydrochloride extended-release tablets, USP 750 mg, on account of ‘CGMP Deviations: FDA analysis detected n-nitrosodimethylamine (NDMA) levels in excess of the acceptable daily intake limit.’ The voluntary ongoing nationwide recall in the US is a class-II recall. Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

887.50 -9.10 (-1.01%)
29-Jan-2026 13:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1597.90
Dr. Reddys Lab 1200.00
Cipla 1319.40
Zydus Lifesciences 887.50
Lupin 2120.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×